E J Cameron
- Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developmentsE J Cameron
Respiratory Medicine, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK
Clin Exp Allergy 42:1302-12. 2012..Potentially novel macrolides may overcome a significant barrier to the use of this type of drug for the long-term treatment of chronic inflammatory airway diseases...